FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

215111000001101: Catapres 100microgram tablets (Glenwood GmbH) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
616901000001114 Catapres 100microgram tablets (Glenwood GmbH) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
616921000001119 Catapres 100microgram tablets (Glenwood GmbH) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Catapres 100microgram tablets (Glenwood GmbH) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Is a Product containing precisely clonidine hydrochloride 100 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Has excipient Lactose false Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Has active ingredient Clonidine hydrochloride false Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Is a Catapres true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Has specific active ingredient Clonidine hydrochloride true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Catapres 100microgram tablets (Glenwood GmbH) 100 tablet 10 x 10 tablets Is pack of False Catapres 100microgram tablets (Glenwood GmbH) Inferred relationship Existential restriction modifier
Catapres 100microgram tablets (Glenwood GmbH) 100 tablet 10 x 10 tablets Has AMP True Catapres 100microgram tablets (Glenwood GmbH) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start